Colorectal cancer metastatic
Not recruitingStudy of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
- Disease:Colorectal cancer metastatic
- Substances:BevacizumabCapecitabine+3
France- Participants:18–64 years · 65+ years
- Substances:Bevacizumab
- Sponsor:Fondation Franc.Cancerologie Digestive






